Multimodality adjuvant treatment is associated with a survival benefit for patients with stage IIIC uterine carcinosarcoma

被引：0
|
作者：
Nasioudis, Dimitrios [1 ]
McMinn, Erin [1 ]
Ko, Emily [1 ]
Haggerty, Ashley [1 ]
Cory, Lori [1 ]
Giuntoli, Robert [1 ]
Kim, Sarah [1 ]
Morgan, Mark [1 ]
Latif, Nawar [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [21] D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
    Peng, Jin
    Wei, Yuehua
    Zhou, Fuxiang
    Dai, Jing
    Zhong, Yahua
    Xie, Conghua
    Qin, Yue'e
    Gong, Jun
    Xiong, Bin
    Zhou, Yunfeng
    CANCER MEDICINE, 2016, 5 (10): : 2773 - 2780
  • [22] EVALUATION OF THE IMPACT OF POSTOPERATIVE ADJUVANT THERAPY ON SURVIVAL AND RECURRENCE PATTERNS IN STAGE I-IV UTERINE CARCINOSARCOMA
    Mceachron, J.
    Chen, Y-J
    Zhou, N.
    Gorelick, C.
    Kanis, M.
    Fehniger, J.
    Lee, Y. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A123 - A124
  • [23] Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma
    Kahramanoglu, Ilker
    Demirkiran, Fuat
    Turan, Hasan
    Bese, Tugan
    Cebi, Sukru
    Ilvan, Sennur
    Arvas, Macit
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (01) : 34 - 42
  • [24] UTERINE CARCINOSARCOMA AFTER ADJUVANT TAMOXIFEN TREATMENT FOR BREAST CANCER
    Wuntakal, R.
    Lane, G.
    Menon, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1406 - 1406
  • [25] Role of surgical staging and adjuvant chemotherapy in the treatment of uterine carcinosarcoma
    Cabrera, O.
    Cho, C.
    Dalmar, A.
    Mahdavi, A.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 96 - +
  • [26] Prognostic factors impacting survival in early stage uterine carcinosarcoma
    Kurnit, Katherine C.
    Previs, Rebecca A.
    Soliman, Pamela T.
    Westin, Shannon N.
    Klopp, Ann H.
    Fellman, Bryan M.
    Lu, Karen H.
    Ramondetta, Lois M.
    Fleming, Nicole D.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (01) : 31 - 37
  • [27] Impact of adjuvant treatment and prognostic variables in women with uterine carcinosarcoma
    Previs, R. A.
    Klopp, A. H.
    Soliman, P. T.
    Westin, S. N.
    Lu, K. H.
    Fellman, B.
    Ramondetta, L. M.
    Fleming, N. D.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 217 - 218
  • [28] Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes
    Yilmaz, Ugur
    Alanyali, Senem
    Aras, Arif Bulent
    Ozsaran, Zeynep
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) : 1377 - 1382
  • [29] META-ANALYSIS COMPARING INFLUENCE OF NO ADJUVANT TREATMENT, POSTOPERATIVE RADIOTHERAPY AND/OR CHEMOTHERAPY ON SURVIVAL IN PATIENTS AFTER PRIMARY SURGERY INCLUDING LYMPHADENECTOMY FOR EARLY STAGE UTERINE CARCINOSARCOMA
    Student, V.
    Garzon, S.
    Prokop, L.
    Murad, M. H.
    Sedlakova, I.
    Mariani, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A17 - A18
  • [30] Adjuvant treatment for stage IIIC endometrial cancer: Options and controversies
    Shah, Pratish H.
    Kudrimoti, Mahesh
    Feddock, Jonathan
    Randall, Marcus
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 675 - 683
12345